HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience.

AbstractINTRODUCTION:
Clinical trials data concerning use of nusinersen in older spinal muscular atrophy (SMA) patients is lacking. We describe our center's experience in using intrathecal nusinersen for older patients in the clinical setting.
METHODS:
Retrospective study.
RESULTS:
Twelve patients (12-52 years old) were treated with nusinersen. Mean follow-up duration was 17.4 months (range, 4-26 months). All patients had scoliosis; 10 had spinal fusion/instrumentation. All procedures (30 cervical and 57 lumbar punctures) were technically successful. The only side effects were postprocedural headache (9%) and site pain (5.7%). Functional assessments showed stability in 6/9 patients and improvement in 3/9 patients. Subjective improvements in endurance, hand strength, and bulbar functioning critical for activities of daily living were reported in 8/12 patients. None of the patients has discontinued treatment so far.
DISCUSSION:
Intrathecal nusinersen can be safely delivered in older SMA patients. Available functional outcome measures are not adequate to capture meaningful subjective improvements.
AuthorsAravindhan Veerapandiyan, Katy Eichinger, Debra Guntrum, Jennifer Kwon, Lindsay Baker, Erin Collins, Emma Ciafaloni
JournalMuscle & nerve (Muscle Nerve) Vol. 61 Issue 2 Pg. 222-226 (02 2020) ISSN: 1097-4598 [Electronic] United States
PMID31773738 (Publication Type: Journal Article)
Copyright© 2019 Wiley Periodicals, Inc.
Chemical References
  • Oligonucleotides
  • nusinersen
Topics
  • Activities of Daily Living
  • Adolescent
  • Adult
  • Child
  • Cross-Sectional Studies
  • Female
  • Follow-Up Studies
  • Hand Strength
  • Humans
  • Injections, Spinal
  • Male
  • Middle Aged
  • Muscular Atrophy, Spinal (drug therapy)
  • Oligonucleotides (administration & dosage, adverse effects, therapeutic use)
  • Physical Endurance
  • Retrospective Studies
  • Scoliosis (complications)
  • Spinal Fusion
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: